Taro Ohba - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Taro Ohba

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Surgery Today|December 30, 2015

Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinomaTaro Ohba, Gouji Toyokawa, Atsushi Osoegawa, et al.

Surgery Today|November 28, 2012

Regression of thymoma associated with a multilocular thymic cyst: report of a caseGouji Toyokawa, Kenichi Taguchi, Taro Ohba, et al.

Thoracic Cancer|July 25, 2019

Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patientsNaoki Haratake, Takashi Seto, Shinkichi Takamori, et al.

Journal of Thoracic Disease|October 29, 2019

Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumabTaro Ohba, Shinkichi Takamori, Ryo Toyozawa, et al.

The Annals of Thoracic Surgery|September 4, 2013

Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancerMasafumi Yamaguchi, Gouji Toyokawa, Taro Ohba, et al.

Lung Cancer (Amsterdam, Netherlands)|July 2, 2011

Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: a case reportTaro Ohba, Kenji Sugio, Takuro Kometani, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Surgery Today|December 30, 2015

Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinomaTaro Ohba, Gouji Toyokawa, Atsushi Osoegawa, et al.

Surgery Today|November 28, 2012

Regression of thymoma associated with a multilocular thymic cyst: report of a caseGouji Toyokawa, Kenichi Taguchi, Taro Ohba, et al.

Thoracic Cancer|July 25, 2019

Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patientsNaoki Haratake, Takashi Seto, Shinkichi Takamori, et al.

Journal of Thoracic Disease|October 29, 2019

Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumabTaro Ohba, Shinkichi Takamori, Ryo Toyozawa, et al.

The Annals of Thoracic Surgery|September 4, 2013

Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancerMasafumi Yamaguchi, Gouji Toyokawa, Taro Ohba, et al.

Lung Cancer (Amsterdam, Netherlands)|July 2, 2011

Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: a case reportTaro Ohba, Kenji Sugio, Takuro Kometani, et al.

Pageof 3